Niche Personalization Adyn targets birth control personalization based on genetic risk and hormone profile, presenting a sales opportunity to partner with healthcare providers, clinics, and insurance programs seeking precision contraception solutions and reduced side effects for patients.

Early Growth With a small team and early revenue, there is an opportunity to engage early adopters in academic medical centers, fertility clinics, and telehealth platforms to scale validated results and collect real-world data to drive evidence-based adoption.

Women’s Health Gap Adyn positions itself to close the gender health gap, which can be leveraged to collaborate with patient advocacy groups, GPOs, and employer health plans focused on women’s health, preventive care, and personalized medicine initiatives.

Data-Driven Partnerships The Birth Control Test creates a data-rich proposition. Sales efforts can target CROs, biobanks, and digital health platforms interested in patient-centered data sharing, anonymized research participation, and broader sex-based biomedical insights.

Technology Stack Advantage Leverage Adyn’s digital and cloud infrastructure to propose integration with EHRs, telemedicine workflows, and marketing platforms, enabling seamless order of testing, consented data collection, and automated follow-ups for ongoing patient support.